EMA Authorised: Aloxi (palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd.

View source ↗

Summary

Aloxi (palonosetron hydrochloride) has been authorised in the EU for use related to vomiting and cancer indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Vomiting

Drugs mentioned

• Aloxi (palonosetron hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Vomiting;Cancer. MAH: Helsinn Birex Pharmaceuticals Ltd.. Decision date: 26/04/2018